Clinical Trial Patient Recruitment Services Industry Overview
The global clinical trial patient recruitment services market size was valued at USD 779.5 million in 2021 and is expected to expand at a CAGR of 8.0% from 2022 to 2030.
The global market has noticed significant growth owing to the increasing rate of clinical trials, and the rapid growth of the medical and pharmaceutical industries. The COVID-19 outbreak had momentarily slowed down the process of clinical studies in 2020, due to the lockdown implemented by the government, which had a negative impact on the market.
Clinical studies are conducted to collect data regarding the efficacy and safety of the new medical devices and drug development. As the number of patients needed for clinical trials increases for the purpose of regulatory and safety issues which drive trends toward longer and larger trials, thus simultaneously increasing the demand for patient recruitment services.
Gather more insights about the market drivers, restrains and growth of the Global Clinical Trial Patient Recruitment Services Market
Patient recruitment is one of the major aspects of ensuring the success of a clinical trial. On-time recruitment of patients and investigators is a challenge for clinical trial organizations. Moreover, patient retention through engagement is another major factor that is often overlooked.
Furthermore, it is evident that the majority of the clinical trials fail due to poor patient recruitment. For instance, as per a white paper published by Clinithink, 46% of the clinical studies fail due to poor recruitment, and 30% of the total time is spent on recruiting patients. Up to 45% of study delays of six months or more can be attributed to recruitment challenges. Clinical trial sponsors have witnessed a significant increase in budgets and the cost of delays. They may lose up to USD 1.3 million per day if a clinical trial is delayed due to recruitment issues.
Restrictions on movement and stay-at-home orders are helping reduce the spread of COVID-19. However, this created an obstacle in clinical trials intended to find effective treatments for various diseases. The integrity of over 330,000 clinical trials registered on Clinicaltrials.gov has been impacted as the novel coronavirus continues to spread worldwide. As of March 26, 2020, at least 18 pharma or biotech companies reported disturbance in clinical trials as a result of the pandemic.
The shift in focus of biopharmaceutical companies on developing vaccines and therapies in response to COVID-19 has resulted in unintended consequences that may disrupt clinical trials for other diseases. Medidata has conducted a frequent analysis of enrollment data from around 4,600 ongoing clinical trials and over 182,000 study sites globally. The report shows a considerable decrease in the number of new patients enrolling in clinical trials for actively recruiting studies. In April 2020, the global average enrollment of new patients reduced by nearly 75%, compared to a 64% decline in March 2020.
However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research. The trend toward more patient-centric trial options has emerged during the pandemic. The industry has been witnessing wide use of decentralized research methods and flexible techniques built around patient safety and convenience.
The clinical trial market as well as the clinical trial patient recruitment management industry acknowledged the benefits of Decentralized Clinical Trials (DCTs), or virtual trials as the optimal solution to regain business as well as make clinical research more efficient & cost-effective.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Clinical Trials Market – The global clinical trials market size was valued at USD 47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. However, the market growth was hindered in 2020 due to the COVID-19 pandemic.
- Clinical Trials Support Services Market – The global clinical trials support services market was estimated at USD 19.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. The global market is projected to expand rapidly due to the rising demand for trials in emerging economies, rising R&D investment, and an increasing number of contract research organizations (CROs).
Clinical Trial Patient Recruitment Services Market Segmentation
Grand View Research has segmented the global clinical trial patient recruitment services market based on service, therapeutic areas, age group, phase, and region:
Clinical Trial Patient Recruitment Services Service Type Outlook (Revenue, USD Million, 2018 – 2030)
- Patient Recruitment & Registry Services
- Patient Retention Services
- Others
Clinical Trial Patient Recruitment Services Phase Outlook (Revenue, USD Million, 2018 – 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Clinical Trial Patient Recruitment Services Therapeutic Areas Outlook (Revenue, USD Million, 2018 – 2030)
- Respiratory Diseases
- Pain and Anesthesia
- Oncology
- Central Nervous System
- Cardiovascular
- Endocrine
- Anti-Infective
- Others
Clinical Trial Patient Recruitment Services Age Group Outlook (Revenue, USD Million, 2018 – 2030)
- Child (Birth-17 Years)
- Adult (18 – 64 Years)
- Older Adults (65 Years+)
Clinical Trial Patient Recruitment Services Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
- September 2021: Syneos Health partnered with Ride Health, a provider of non-emergency medical transportation (NEMT) for clinical trial participants, this partnership was intended to improve clinical trial recruitment and retention service of Syneos Health by providing transportation facilities to the participants.
- September 2020: ICON launched Accellacare, a clinical research network used for increasing patient recruitment in clinical trials. This network allows patients easy and fast access to advanced treatments and offers patients the option to choose decentralized trials.
Key Companies profiled:
Some prominent players in the global clinical trial patient recruitment services market include
- Antidote
- Clara Health
- Clariness
- BBK Worldwide
- Worldwide Clinical Trials
- Clinical Site Services (CCSi)
- IQVIA
- PPD Inc
- Veristat
- Elligo Health Research
Order a free sample PDF of the Clinical Trial Patient Recruitment Services Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
